Roth Capital Starts Tetralogic Pharmaceuticals (TLOG) at Buy; $5 PT
Tweet Send to a Friend
Roth Capital initiates coverage on Tetralogic Pharmaceuticals (NASDAQ: TLOG) with a Buy rating and a price target of $5.00.Analyst Joseph ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
